Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 91 | 38 | 458 | 1,146 | 625 |
| Cost of Goods | 91 | 38 | 368 | 1,146 | 625 |
| Gross Profit | N/A | N/A | 90 | N/A | N/A |
| Operating Expenses | 10,172 | 7,878 | 10,312 | 9,913 | 10,191 |
| Operating Income | -10,081 | -7,840 | -9,854 | -9,767 | -9,566 |
| Other Income | -1 | -156 | 16 | -83 | -63 |
| Pre-tax Income | -10,082 | -7,996 | -9,838 | -9,850 | -9,629 |
| Income Tax | 106 | 214 | 189 | 199 | 167 |
| Net Income Continuous | -10,188 | -8,210 | -10,027 | -10,049 | -9,796 |
| Net Income | $-10,188 | $-8,210 | $-10,027 | $-10,049 | $-9,796 |
| EPS Basic Total Ops | -0.66 | -0.54 | -0.66 | -0.63 | -0.68 |
| EPS Basic Continuous Ops | -0.66 | -0.54 | -0.66 | -0.63 | -0.68 |
| EPS Diluted Total Ops | -0.66 | -0.54 | -0.66 | -0.63 | -0.68 |
| EPS Diluted Continuous Ops | -0.66 | -0.54 | -0.66 | -0.63 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -0.66 | -0.54 | -0.66 | -0.66 | -0.68 |
| EBITDA(a) | $-10,041 | $-7,789 | $-9,824 | $-9,739 | $-9,520 |